Recent

% | $
Quotes you view appear here for quick access.

Ironwood Pharmaceuticals, Inc. Message Board

yknot451 2 posts  |  Last Activity: Jun 2, 2016 8:01 PM Member since: Aug 2, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    2nd qtr.

    by pepsiberger Jun 2, 2016 1:31 PM
    yknot451 yknot451 Jun 2, 2016 8:01 PM Flag

    Well, put this next comment in the FWIW category - or more accurately FWIW on a Yahoo MB category. Let's just assume that I personally know of 50+ people with cancer at the moment/various stages. Some have insurance; some do not and have nothing left, save the "system" and the generosity of others. Even those with insurance are facing financial hardship as a result/for one reason or another. $900 bucks is a lot of money to someone who has nothing. And if the insurance carrier will only cover one test (vs. two/a "duplicate") and I'm a doc, I'm going with the "safe" choice. I need a law suit like I need a hole in the head. Too much down-side...in investment terms that would be "minimize risk." My humble (MB) opine is that IF (note all caps again), repeat IF, the tests are legit...and all indications are they are, there will be a point where the damn breaks. I don't think they will ramp up to the hockey stick/growth curve; I THINK, they will either be a total failure or an overnight sensation. It's one or the other. Again, IMO humble (MB) opine. In the meantime, I've accumulated 30,000 shares. No big deal, but I'm betting on $35 long before $0.... The market cap it would take to hit $35 - even with some dilution - is a rounding error to some of the companies who might acquire.

    Sentiment: Buy

  • Reply to

    2nd qtr.

    by pepsiberger Jun 2, 2016 1:31 PM
    yknot451 yknot451 Jun 2, 2016 4:47 PM Flag

    "this is not a new method of brain surgery we are talking about here---the change should be easy.." I would disagree. Am fairly senior in the world of cancer. If there's only enough money to do one test vs. something radically new + a backup, you go with what you've always done. Safer on a number of levels, including, but not limited to the risk of a malpractice lawsuit/misdiagnosis from something so different/early stage. At some point, there will be an overwhelming amount of evidence with higher trial numbers and even successful results - a tipping point. Then, the revenue will pour in. Like I've said, IF (note all caps) this is the real deal, the company will be worth billions. I suspect they know that and with the amount of cash they are sitting on, they are willing to wait it out.

    Sentiment: Buy

IRWD
13.500.00(0.00%)Aug 25 4:00 PMEDT